Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Haans

Karyopharm Therapeutics Inc.
Start price
€26.19
11.03.15 / 50%
Target price
€30.00
17.03.15
Performance (%)
17.36%
End price
€30.73
17.03.15
Summary
This prediction ended on 17.03.15 with a price of €30.73. The prediction had a final performance of 17.36%. Haans has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Karyopharm Therapeutics Inc. - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by Haans for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 17.36%
Target price 30.000
Change
Ends at 17.03.15

Ausbruch...

Mit dem heutigen Kaufsignal sind bald Kurse von über 30 Euro drin.

Haans 
0
Report Share
11.03.15
Prediction Buy
Perf. (%) 17.36%
Target price 30.000
Change
Ends at 17.03.15

(Zielkurs erreicht)

Haans 
0
Report Share
17.03.15